總體基因體學市場規模、佔有率和成長分析：按產品、技術、工作流程、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球總體基因體學市場價值為 28 億美元，預計到 2025 年將成長至 31.6 億美元，到 2033 年將成長至 84.1 億美元，在預測期（2026-2033 年）內複合年成長率為 13.0%。

全球宏總體基因體學市場的發展主要得益於定序成本的下降以及高通量定序和生物資訊技術的進步，從而能夠有效地分析複雜的微生物群落。該市場涵蓋了用於分析各種樣本中DNA和RNA的技術、試劑、平台和分析方法，凸顯了微生物組成在人類健康、生態系統平衡和工業過程中發揮的關鍵作用。從傳統的依賴培養的方法轉向先進的鳥槍法和總體基因體學，反映了該領域的顯著進步。增強的生物資訊學能力和可擴展的資料基礎設施對於管理海量資料集至關重要，這使得總體基因體學能夠在臨床診斷、環境監測和農業最佳化等領域中實際應用。這種成長正在推動對雲端解決方案、人工智慧驅動的分析以及創新型「樣本到結果」儀器的需求，從而創造商業性機會並拓展診斷應用。

全球總體基因體學市場促進因素

全球總體基因體學市場的發展得益於定序基礎設施的大量投資、廣泛的實驗室網路以及計算能力的提升，這些因素共同推動了總體基因體學的應用。這些進步縮短了報告時間，並擴大了研發和臨床領域取得結果的途徑。這種環境促進了合作，並透過建立高效的流程和共用資源加速了創新應用的開發。因此，更多機構能夠將元基因組分析工作流程無縫整合到日常研究中，而無需承擔過高的成本。這種快速成長的趨勢正在促進各類終端用戶對宏基因組學的持續需求和市場成熟，推動平台和試劑的商業化，拓展服務範圍，並降低市場進入門檻。

全球總體基因體學市場的限制因素

全球元基因組市場面臨許多限制因素，主要源自於高通量定序儀、樣本製備系統和先進計算基礎設施所需的大量前期投資。這一資金壁壘對小規模實驗室和機構構成挑戰，阻礙了它們採用這些技術，並減緩了市場成長。此外，由於常規臨床檢測和現有傳統診斷平台缺乏預算撥款，總體基因體學的資金投入往往優先順序較低，導致儀器採購和試點部署過程耗時過長。對維護、耗材和專業人員需求等持續成本的擔憂進一步阻礙了其廣泛應用，使得集中式機構和服務供應商更受青睞。這導致儀器直接銷售額下降，而元基因組學檢測正變得越來越分散，跨越地理和組織界限。

全球總體基因體學市場趨勢

全球宏總體基因體學市場正呈現出向臨床即時檢測（照護現場的顯著趨勢，這主要受快速病原體鑑定和基於微生物組的治療策略需求的驅動。這項轉變的特點是檢體處理流程簡化、介面友好，以及針對醫療工作流程量身定做的、具有臨床實用性的報告功能不斷提升。診斷設備製造商與醫療服務提供者之間的合作正在加速宏基因組學的應用，重點在於易於解讀、品質保證以及與電子健康記錄的無縫整合。這一發展趨勢正在提升宏基因體學在感染疾病管理、移植醫學和個人化醫療選擇方面的臨床效用，從而刺激了醫療機構對便捷可靠的元基因組解決方案的需求。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球總體基因體學市場規模：依產品分類

• 試劑盒和試劑
• 定序和數據分析服務
• 軟體和生物資訊學工具
• 設備/耗材

全球總體基因體學市場規模：依技術分類

• 霰彈槍定序
• 16S rRNA測序
• 全基因組定序
• 第三代長讀長定序
• 功能主導的總體基因體學

全球總體基因體學市場規模：依工作流程分類

• 序列預處理
• 定序
• 數據分析與解讀

全球總體基因體學市場規模：依應用領域分類

• 臨床診斷與人體健康
• 環境監測與生物修復
• 藥物發現
• 農業和食品安全檢查
• 生物技術及工業應用

全球總體基因體學市場規模：依最終用戶分類

• 學術研究機構
• 製藥和生物技術公司
• 臨床實驗室
• 環境與食品檢測實驗室
• 受託研究機構（CRO）
• 其他

全球總體基因體學市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Illumina, Inc.
• Thermo Fisher Scientific, Inc.
• QIAGEN NV
• F. Hoffmann-La Roche Ltd
• PerkinElmer, Inc.（Revvity）
• BGI Group
• Novogene Co., Ltd.
• Eurofins Scientific SE
• Oxford Nanopore Technologies plc
• Pacific Biosciences of California, Inc.（PacBio）
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Promega Corporation
• Merck KGaA
• Takara Bio, Inc.
• Zymo Research Corporation
• Azenta Life Sciences（Genewiz）
• CosmosID Inc.
• GenScript Biotech Corporation
• Diversigen, Inc.

結論與建議

Global Metagenomics Market size was valued at USD 2.8 Billion in 2024 and is poised to grow from USD 3.16 Billion in 2025 to USD 8.41 Billion by 2033, growing at a CAGR of 13.0% during the forecast period (2026-2033).

The global metagenomics market is fueled by the reduction in sequencing costs and advances in high-throughput sequencing and bioinformatics, facilitating efficient profiling of complex microbial communities. This market encompasses technologies, reagents, platforms, and analytics that analyze DNA and RNA from various samples, highlighting the crucial role of microbial composition in human health, ecological balance, and industrial processes. Transitioning from traditional culture-dependent methods to advanced shotgun and long-read metagenomics reflects significant progress in the field. Enhanced bioinformatics capabilities and scalable data infrastructures are essential for managing the vast datasets generated, enabling the practical application of metagenomics in clinical diagnostics, environmental monitoring, and agricultural optimization. This growth fosters demand for cloud solutions, AI-driven analytics, and innovative sample-to-answer instruments, driving commercial opportunities and expanding diagnostic applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Metagenomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Metagenomics Market Segments Analysis

Global metagenomics market is segmented by product, technology, workflow, application, end-user and region. Based on product, the market is segmented into Kits & Reagents, Sequencing & Data Analytics Services, Software & Bioinformatics Tools and Instruments & Consumables. Based on technology, the market is segmented into Shotgun Sequencing, 16S rRNA Sequencing, Whole Genome Sequencing, Third-Generation Long-Read Sequencing and Function-Driven Metagenomics. Based on workflow, the market is segmented into Pre-sequencing, Sequencing and Data Analysis & Interpretation. Based on application, the market is segmented into Clinical Diagnostics & Human Health, Environmental Monitoring & Bioremediation, Drug Discovery, Agriculture & Food Safety Testing and Biotechnology & Industrial Applications. Based on end-user, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Clinical Diagnostic Laboratories, Environmental & Food Testing Labs, Contract Research Organizations (CROs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Metagenomics Market

The global metagenomics market is propelled by significant investment in sequencing infrastructure, extensive laboratory networks, and enhanced computational capabilities, all of which streamline the adoption of metagenomics. These advancements lead to shorter turnaround times and broaden access in both research and clinical environments. This environment fosters collaborations and accelerates the development of innovative applications by establishing efficient pipelines and shared resources. Consequently, more institutions can seamlessly integrate metagenomic workflows into their routine studies without incurring excessive costs. This burgeoning landscape cultivates consistent demand and market maturation across various end-users, facilitating the commercialization of platforms, reagents, and service expansions while lowering entry barriers.

Restraints in the Global Metagenomics Market

The Global Metagenomics market faces significant restraints primarily due to the substantial upfront investment needed for high-throughput sequencers, sample preparation systems, and advanced computational infrastructure. This financial barrier poses challenges for smaller laboratories and institutions, hindering their ability to adopt these technologies and, consequently, stunting market growth. Additionally, the absence of allocated budgets for routine clinical assays and existing traditional diagnostic platforms means that funding for metagenomics often takes a back seat, prolonging the procurement and pilot implementation processes. Concerns regarding ongoing costs for maintenance, consumables, and the need for skilled personnel further discourage widespread adoption, resulting in a preference for centralized facilities or service providers. This creates a decline in direct equipment sales and leads to increased decentralization of metagenomic testing across various geographical and institutional boundaries.

Market Trends of the Global Metagenomics Market

The global metagenomics market is witnessing a significant trend toward clinical point-of-care integration, driven by the need for rapid pathogen identification and microbiome-informed therapeutic strategies. This shift is characterized by advancements in simplified sample handling, user-friendly interfaces, and clinically actionable reporting tailored to healthcare workflows. Collaborations between diagnostic manufacturers and healthcare providers are fostering accelerated adoption, with a strong emphasis on interpretability, quality assurance, and seamless integration with electronic health records. This growing trend enhances clinical utility across infectious disease management, transplant care, and personalized therapy selection, thereby stimulating demand for accessible and reliable metagenomic solutions in healthcare settings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Metagenomics Market Size by Product & CAGR (2026-2033)

• Market Overview
• Kits & Reagents
• Sequencing & Data Analytics Services
• Software & Bioinformatics Tools
• Instruments & Consumables

Global Metagenomics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Shotgun Sequencing
• 16S rRNA Sequencing
• Whole Genome Sequencing
• Third-Generation Long-Read Sequencing
• Function-Driven Metagenomics

Global Metagenomics Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• Pre-sequencing
• Sequencing
• Data Analysis & Interpretation

Global Metagenomics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Diagnostics & Human Health
• Environmental Monitoring & Bioremediation
• Drug Discovery
• Agriculture & Food Safety Testing
• Biotechnology & Industrial Applications

Global Metagenomics Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Clinical Diagnostic Laboratories
• Environmental & Food Testing Labs
• Contract Research Organizations (CROs)
• Others

Global Metagenomics Market Size & CAGR (2026-2033)

• North America (Product, Technology, Workflow, Application, End-User)
  • US
  • Canada
• Europe (Product, Technology, Workflow, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Workflow, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Workflow, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Workflow, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (Revvity)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (PacBio)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymo Research Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta Life Sciences (Genewiz)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CosmosID Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diversigen, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations